# A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

> **NCT07053137** · — · ACTIVE_NOT_RECRUITING · sponsor: **Yipeng Liu** · enrollment: 180 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Telitacicept
- Belimumab
- Efficacy and Safety

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07053137
- **Lead sponsor:** Yipeng Liu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-30
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053137, "A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07053137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*